Placebo (PB) Clinical Trials
2 recruitingDrug
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Healthy Volunteers
Regeneron Pharmaceuticals172 enrolled6 locationsNCT05648214
Recruiting
Phase 1Phase 2
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Regeneron Pharmaceuticals42 enrolled16 locationsNCT06351592